(PRLD) Prelude Therapeutics - Performance -80.8% in 12m
Compare PRLD with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-89.24%
#170 in Group
Rel. Strength
3.90%
#7647 in Universe
Total Return 12m
-80.81%
#157 in Group
Total Return 5y
-97.02%
#159 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -
(?) Percentile in Group
12m Total Return: PRLD (-80.8%) vs XBI (-14%)
5y Drawdown (Underwater) Chart
Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| UTHR NASDAQ United Therapeutics |
2.95% | 13.3% | 161% | 12.1 | 11 | 1.43 | 74.6% | 16.1% |
| HLN NYSE Haleon |
12.6% | 32.2% | 49.3% | 24.4 | 20.2 | 1.79 | 69.1% | 13.6% |
| AMGN NASDAQ Amgen |
-8.67% | -12.4% | 27.7% | 25.5 | 13.5 | 0.95 | 0.60% | 41% |
| LONN SW Lonza |
15.8% | 12% | 33.5% | 67.1 | 35.1 | 1.28 | 2.20% | -12.5% |
| BIM PA Biomerieux |
4.68% | 18.2% | -1.63% | 32.5 | 25.2 | 1.52 | -38.5% | -25.1% |
| KMDA NASDAQ Kamada |
14.1% | 27.3% | -5.64% | 26.6 | 23.9 | 0.96 | 32.5% | 3.93% |
| NBIX NASDAQ Neurocrine Biosciences |
21.4% | -17.2% | 1.88% | 32.3 | 21.6 | 0.27 | 68.0% | 31.9% |
| ERF PA Eurofins Scientific SE |
22.4% | 0.59% | 8.05% | 26.6 | 13.6 | 0.56 | -66.6% | -17.1% |
Performance Comparison: PRLD vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for PRLD
| Total Return (including Dividends) | PRLD | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 17.50% | 2.02% | 2.87% |
| 3 Months | -28.35% | -15.44% | -6.42% |
| 12 Months | -80.81% | -14.02% | 9.87% |
| 5 Years | -97.02% | -26.47% | 107.51% |
| Trend Score (consistency of price movement) | PRLD | XBI | S&P 500 |
| 1 Month | 39.2% | 57% | 89.4% |
| 3 Months | -4.60% | -82.3% | -72% |
| 12 Months | -88.9% | -53.1% | 49.3% |
| 5 Years | -92.4% | -53.9% | 84.1% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
| 1 Month | #67 | 15.2% | 14.2% |
| 3 Month | #110 | -15.3% | -23.4% |
| 12 Month | #158 | -77.7% | -82.5% |
| 5 Years | #157 | -95.7% | -98.4% |
FAQs
Does PRLD Prelude Therapeutics outperforms the market?
No,
over the last 12 months PRLD made -80.81%, while its related Sector, the SPDR S&P Biotech (XBI) made -14.02%.
Over the last 3 months PRLD made -28.35%, while XBI made -15.44%.
Over the last 3 months PRLD made -28.35%, while XBI made -15.44%.
Performance Comparison PRLD vs Indeces and Sectors
PRLD vs. Indices PRLD is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -11.6% | 14.6% | -29.2% | -90.7% |
| US NASDAQ 100 | QQQ | -11.8% | 12.8% | -29.6% | -92.1% |
| US Dow Jones Industrial 30 | DIA | -11.8% | 15.9% | -28.2% | -87.2% |
| German DAX 40 | DAX | -13.7% | -1.78% | -54.8% | -106% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -12.2% | 11.2% | -28.5% | -86.4% |
| Hongkong Hang Seng | HSI | -15.1% | 1.29% | -38.7% | -92.9% |
| India NIFTY 50 | INDA | -9.17% | 15.2% | -31.1% | -83.1% |
| Brasil Bovespa | EWZ | -13.6% | 5.97% | -38.4% | -74.3% |
PRLD vs. Sectors PRLD is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -11.7% | 13.8% | -35.4% | -101% |
| Consumer Discretionary | XLY | -12.5% | 14.0% | -27.0% | -94.9% |
| Consumer Staples | XLP | -11.2% | 15.5% | -36.1% | -88.4% |
| Energy | XLE | -12.5% | 17.4% | -23.2% | -71.1% |
| Financial | XLF | -12.2% | 11.9% | -35.1% | -102% |
| Health Care | XLV | -7.77% | 21.9% | -24.0% | -74.9% |
| Industrial | XLI | -13.1% | 10.1% | -30.2% | -90.8% |
| Materials | XLB | -11.6% | 12.8% | -25.2% | -74.8% |
| Real Estate | XLRE | -11.2% | 11.4% | -31.6% | -94.3% |
| Technology | XLK | -12.5% | 10.8% | -27.0% | -87.8% |
| Utilities | XLU | -12.6% | 11.9% | -37.0% | -96.7% |
| Aerospace & Defense | XAR | -12.1% | 8.16% | -38.5% | -106% |
| Biotech | XBI | -3.48% | 15.5% | -8.16% | -66.8% |
| Homebuilder | XHB | -11.1% | 14.4% | -15.6% | -71.1% |
| Retail | XRT | -11.7% | 13.9% | -22.9% | -76.5% |